| Approved Symbol |
Approved Name |
Type |
No. of Studies (Positive/Negative) |
Evidence |
| FGF2 |
fibroblast growth factor 2 (basic) |
Literature-origin
|
2(2/0) |
IGI[8663044]
|
| TBX1 |
T-box 1 |
Literature-origin
|
1(0/1) |
ISS
|
| EGF |
epidermal growth factor |
Literature-origin; SNP mapped; Protein mapped
|
1(0/1) |
IDA
|
| CCKBR |
cholecystokinin B receptor |
Literature-origin
|
2(2/0) |
IDA[10913157]
|
| IL15 |
interleukin 15 |
Literature-origin
|
2(2/0) |
TAS[10851076]
|
| IL3 |
interleukin 3 (colony-stimulating factor, multiple) |
Literature-origin
|
1(1/0) |
ISS
|
| ADRA2A |
adrenoceptor alpha 2A |
Literature-origin; Protein mapped
|
2(2/0) |
TAS[10896916]
|
| PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
Literature-origin
|
1(1/0) |
IMP[19749791]
|
| IL9 |
interleukin 9 |
Literature-origin
|
1(1/0) |
TAS[1680606]
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
Literature-origin; SNP mapped; Protein mapped
|
9(7/2) |
IEA
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
Literature-origin; SNP mapped; Protein mapped
|
13(11/2) |
TAS[1330092]
|
| RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
Literature-origin
|
1(1/0) |
IEA
|
| FGF9 |
fibroblast growth factor 9 (glia-activating factor) |
Literature-origin
|
1(1/0) |
IDA[8321227]
|
| FZR1 |
fizzy/cell division cycle 20 related 1 (Drosophila) |
Literature-origin
|
1(1/0) |
IEA
|
| BCL2L1 |
BCL2-like 1 |
Literature-origin
|
1(1/0) |
IEA
|
| VEGFA |
vascular endothelial growth factor A |
Literature-origin
|
1(1/0) |
IDA[7929439]
|
| FGF1 |
fibroblast growth factor 1 (acidic) |
Literature-origin
|
1(1/0) |
IGI[18187602]
|
| ADCYAP1 |
adenylate cyclase activating polypeptide 1 (pituitary) |
Literature-origin
|
1(1/0) |
IEA
|
| PTH1R |
parathyroid hormone 1 receptor |
Literature-origin
|
1(1/0) |
IEA
|
| FGFR1 |
fibroblast growth factor receptor 1 |
Literature-origin
|
3(3/0) |
IDA[8663044]; IGI[8663044]; IMP[8622701]
|
| IL2 |
interleukin 2 |
Literature-origin; Protein mapped
|
1(1/0) |
TAS[8476561]
|
| NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
Literature-origin
|
2(2/0) |
IDA
|
| IL6 |
interleukin 6 (interferon, beta 2) |
Literature-origin; Protein mapped
|
1(0/1) |
IDA[2261637]; IMP[18719127]
|
| INS |
insulin |
Literature-origin; Protein mapped
|
1(1/0) |
IDA[17925406]
|
| CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
Literature-origin
|
1(1/0) |
IMP[17498763]
|
| AR |
androgen receptor |
Literature-origin
|
3(3/0) |
IDA[17277772]
|
| FGFR2 |
fibroblast growth factor receptor 2 |
Literature-origin
|
2(2/0) |
IDA[8663044]; IGI[8663044]; IMP[15629145]
|
| EDN1 |
endothelin 1 |
Literature-origin
|
1(1/0) |
IDA[1917960]
|
| HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
Literature-origin
|
1(1/0) |
IMP[15925089]
|
| GREM1 |
gremlin 1, DAN family BMP antagonist |
Literature-origin
|
1(1/0) |
IDA[16545136]
|
| PTN |
pleiotrophin |
Literature-origin
|
1(1/0) |
TAS[2270483]
|
| NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
Literature-origin; SNP mapped; Protein mapped
|
5(5/0) |
ISS
|
| HDAC2 |
histone deacetylase 2 |
Literature-origin
|
1(1/0) |
IMP[18347167]
|
| SIRT1 |
sirtuin 1 |
Literature-origin; SNP mapped
|
1(1/0) |
IMP
|
| FGFR3 |
fibroblast growth factor receptor 3 |
Literature-origin
|
2(2/0) |
IGI[8663044]; IMP[11294897]
|
| SSR1 |
signal sequence receptor, alpha |
Literature-origin
|
1(1/0) |
TAS[10437777]
|
| S100B |
S100 calcium binding protein B |
Literature-origin; Protein mapped
|
3(1/2) |
IEA
|
| MAPK1 |
mitogen-activated protein kinase 1 |
Literature-origin
|
2(2/0) |
IEA
|
| PTK2B |
protein tyrosine kinase 2 beta |
Literature-origin
|
2(2/0) |
IMP[18765415]
|
| UBE2A |
ubiquitin-conjugating enzyme E2A |
Literature-origin
|
1(1/0) |
IDA[11953320]
|
| IL24 |
interleukin 24 |
Literature-origin
|
1(1/0) |
IEA
|
Basic Information